{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:58:00Z","timestamp":1769032680109,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2019-I2M-5-038"],"award-info":[{"award-number":["2019-I2M-5-038"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-1-I2M-012"],"award-info":[{"award-number":["2021-1-I2M-012"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300894"],"award-info":[{"award-number":["81300894"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671006"],"award-info":[{"award-number":["81671006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172876"],"award-info":[{"award-number":["82172876"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Commission","doi-asserted-by":"publisher","award":["2022-2-4027"],"award-info":[{"award-number":["2022-2-4027"]}],"id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.lfs.2025.124171","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T15:56:34Z","timestamp":1766678194000},"page":"124171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RUVBL1-mediated mTORC1 activation drives tumour progression and immune evasion for oral squamous cell carcinoma"],"prefix":"10.1016","volume":"386","author":[{"given":"Xinpei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuxuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengyang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0005","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1038\/s41467-018-05696-2","article-title":"Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer","volume":"9","author":"Carnielli","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0010","article-title":"Oral cancer: a multicenter study","volume":"23","author":"Dhanuthai","year":"2018","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"issue":"5","key":"10.1016\/j.lfs.2025.124171_bb0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.lfs.2025.124171_bb0020","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146707","article-title":"Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function","volume":"6","author":"Petty","year":"2021","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.lfs.2025.124171_bb0025","article-title":"MET inhibitors promote liver tumor evasion of the immune response by stabilizing PDL1","volume":"156","author":"Li","year":"2019","journal-title":"Gastroenterology"},{"issue":"14","key":"10.1016\/j.lfs.2025.124171_bb0030","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1158\/1078-0432.CCR-16-3215","article-title":"PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression","volume":"23","author":"Jiao","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s40001-022-00835-4","article-title":"Tumor microenvironment and immunotherapy of oral cancer","volume":"27","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189230","article-title":"New advances in the therapeutic strategy of head and neck squamous cell carcinoma: a review of latest therapies and cutting-edge research","volume":"1880","author":"Wang","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2025.124171_bb0045","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.it.2017.01.002","article-title":"MYC: master regulator of immune privilege","volume":"38","author":"Casey","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2025.124171_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.883639","article-title":"Modulation of lymphocyte functions in the microenvironment by tumor oncogenic pathways","volume":"13","author":"Seliger","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.lfs.2025.124171_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007479","article-title":"TP53\/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma","volume":"11","author":"Yu","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.lfs.2025.124171_bb0060","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/gutjnl-2023-331519","article-title":"Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1\/2","volume":"73","author":"Vogt","year":"2024","journal-title":"Gut"},{"issue":"7756","key":"10.1016\/j.lfs.2025.124171_bb0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41586-019-1182-7","article-title":"Transcription factors and 3D genome conformation in cell-fate decisions","volume":"569","author":"Stadhouders","year":"2019","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.lfs.2025.124171_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082413","article-title":"Hallmarks of cancer-related newly prognostic factors of Oral squamous cell carcinoma","volume":"19","author":"Sasahira","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.lfs.2025.124171_bb0075","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1002\/ijc.32787","article-title":"Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression","volume":"146","author":"Mello","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2019.12.005","article-title":"RUVBL1\/RUVBL2 ATPase activity drives PAQosome maturation, DNA replication and radioresistance in lung cancer","volume":"27","author":"Yenerall","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"23","key":"10.1016\/j.lfs.2025.124171_bb0085","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1038\/s41388-022-02332-8","article-title":"RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway","volume":"41","author":"Sun","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2025.124171_bb0090","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1007\/s13277-016-5452-9","article-title":"Downregulation of RUVBL1 inhibits proliferation of lung adenocarcinoma cells by G1\/S phase cell cycle arrest via multiple mechanisms","volume":"37","author":"Yuan","year":"2016","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molcel.2012.10.003","article-title":"Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1\/2 complex","volume":"49","author":"Kim","year":"2013","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.lfs.2025.124171_bb0100","article-title":"Cytoplasmic expression of pontin in renal cell carcinoma correlates with tumor invasion, metastasis and patients\u2019 survival","volume":"10","author":"Zhang","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0105","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1038\/s41467-022-33433-3","article-title":"The transcriptional coactivator RUVBL2 regulates Pol II clustering with diverse transcription factors","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.lfs.2025.124171_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2020.03.023","article-title":"Gene-specific control of tRNA expression by RNA polymerase II","volume":"78","author":"Gerber","year":"2020","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.lfs.2025.124171_bb0115","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.molcel.2020.10.001","article-title":"Opposing effects of cohesin and transcription on CTCF organization revealed by super-resolution imaging","volume":"80","author":"Gu","year":"2020","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00018-024-05144-z","article-title":"BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma","volume":"81","author":"Yu","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.lfs.2025.124171_bb0125","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.7150\/ijbs.103703","article-title":"BRD7 inhibited immune escape in nasopharyngeal carcinoma via inhibiting PD-L1 expression","volume":"21","author":"Guo","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"14","key":"10.1016\/j.lfs.2025.124171_bb0130","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.7150\/ijbs.98200","article-title":"Targeting PLCG2 suppresses tumor progression, orchestrates the tumor immune microenvironment and potentiates immune checkpoint blockade therapy for colorectal cancer","volume":"20","author":"Zhou","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12967-024-05888-z","article-title":"PRDX2 induces tumor immune evasion by modulating the HDAC3-Galectin-9 axis in lung adenocarcinoma cells","volume":"23","author":"Dong","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0140","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2376264","article-title":"SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion","volume":"13","author":"Chen","year":"2024","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.lfs.2025.124171_bb0145","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/s12276-023-01060-7","article-title":"Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice","volume":"55","author":"Zhang","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.lfs.2025.124171_bb0150","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.apsb.2021.03.039","article-title":"Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"36","key":"10.1016\/j.lfs.2025.124171_bb0155","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1038\/s41388-018-0314-0","article-title":"Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy","volume":"37","author":"Zhu","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.lfs.2025.124171_bb0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1158\/2326-6066.CIR-19-0394","article-title":"Targeting CMTM6 suppresses stem cell-like properties and enhances antitumor immunity in head and neck squamous cell carcinoma","volume":"8","author":"Chen","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10120-023-01446-6","article-title":"Gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy","volume":"27","author":"Wang","year":"2024","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.lfs.2025.124171_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2019.09.011","article-title":"Translational genomics and recent advances in oral squamous cell carcinoma","volume":"61","author":"Chai","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.lfs.2025.124171_bb0175","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1158\/1078-0432.CCR-23-3477","article-title":"Targeting dendritic cell dysfunction to circumvent anti-PD1 resistance in head and neck cancer","volume":"30","author":"Saito","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1349-7006.2011.02112.x","article-title":"Heat shock protein 90 regulates phosphatidylinositol 3-kinase-related protein kinase family proteins together with the RUVBL1\/2 and Tel2-containing co-factor complex","volume":"103","author":"Izumi","year":"2012","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.lfs.2025.124171_bb0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1083\/jcb.201404160","article-title":"Proteomic and 3D structure analyses highlight the C\/D box snoRNP assembly mechanism and its control","volume":"207","author":"Bizarro","year":"2014","journal-title":"J. Cell Biol."},{"issue":"31","key":"10.1016\/j.lfs.2025.124171_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay9131","article-title":"Synthetic lethality by targeting the RUVBL1\/2-TTT complex in mTORC1-hyperactive cancer cells","volume":"6","author":"Shin","year":"2020","journal-title":"Sci. Adv."},{"issue":"19","key":"10.1016\/j.lfs.2025.124171_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197200","article-title":"Ceramide-enriched membrane domains contribute to targeted and nontargeted effects of radiation through modulation of PI3K\/AKT signaling in HNSCC cells","volume":"21","author":"Ladjohounlou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2025.124171_bb0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-14-3362","article-title":"Control of PD-L1 expression by oncogenic activation of the AKT-mTOR pathway in non-small cell lung cancer","volume":"76","author":"Lastwika","year":"2016","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2025.124171_bb0205","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN promotes resistance to T cell-mediated immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discov."},{"issue":"9\u201310","key":"10.1016\/j.lfs.2025.124171_bb0210","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10495-024-01982-1","article-title":"FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma","volume":"29","author":"Wang","year":"2024","journal-title":"Apoptosis"},{"issue":"5","key":"10.1016\/j.lfs.2025.124171_bb0215","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s42255-024-01037-4","article-title":"Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc","volume":"6","author":"Wang","year":"2024","journal-title":"Nat. Metab."},{"issue":"6","key":"10.1016\/j.lfs.2025.124171_bb0220","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1158\/2326-6066.CIR-22-0374","article-title":"EBV-upregulated B7-H3 inhibits NK cell-mediated antitumor function and contributes to nasopharyngeal carcinoma progression","volume":"11","author":"Chen","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"12","key":"10.1016\/j.lfs.2025.124171_bb0225","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1007\/s00262-023-03520-5","article-title":"PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies","volume":"72","author":"Lin","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0230","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.det.2022.07.007","article-title":"Targeted therapy and immunotherapy in melanoma","volume":"41","author":"Lazaroff","year":"2023","journal-title":"Dermatol. Clin."},{"issue":"1","key":"10.1016\/j.lfs.2025.124171_bb0235","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13046-024-03191-9","article-title":"Mediator complex subunit 1 promotes oral squamous cell carcinoma progression by activating MMP9 transcription and suppressing CD8(+) T cell antitumor immunity","volume":"43","author":"Li","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525008070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525008070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:58:53Z","timestamp":1768975133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525008070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"alternative-id":["S0024320525008070"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.124171","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RUVBL1-mediated mTORC1 activation drives tumour progression and immune evasion for oral squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.124171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124171"}}